Categories AlphaGraphs, Health Care

BIIB Earnings: Key quarterly highlights from Biogen’s Q4 2021 financial results

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today.

Total revenue decreased 4% year-over-year to $2.73 billion.

GAAP net income attributable to Biogen Inc. was $368 million, or $2.50 per share, compared to $358 million, or $2.32 per share, last year. Adjusted net income was $500 million, or $3.39 per share.

For the full year of 2022, Biogen expects revenue to range between $9.7-10 billion and adjusted EPS to range between $14.25-16.00.

Prior performance

Biogen Q3 2021 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Stock Watch: AutoZone (AZO) stays on the fast track despite cost pressures

AutoZone, Inc. (NYSE: AZO) is a much sought-after automotive parts retailer among do-it-yourself customers, especially after the virus-related movement restrictions forced people to stay indoors. The company’s stock has remained

Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for minimally invasive surgery, help healthcare professionals conduct procedures

WBA Stock: Why you should add Walgreens Boots to your watchlist

Drugstore chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) witnessed a spike in customer traffic in the last couple of years due to the vaccination drive and the high demand for

Add Comment
Viewing Highlight